Monthly Archives: October 2018

Targeted Medical Pharma Files SEC Form 15

Los Angeles – October 19, 2018 –  Targeted Medical Pharma a United States based medical nutrition and dietary supplement manufacturer, filed a Form 15 with the Securities and Exchange Commission. “After a detailed analysis and thoughtful deliberation of the advantages and disadvantages of being an SEC reporting company, the company’s board of directors and management concluded that the costs of reporting are too high and unreasonably burdensome on a company that is restructuring and rebuilding,” said interim Managing Director, Marcus Charuvastra.  According to Mr. Charuvastra, “The preparation Continue reading →